FIELD: biotechnologies.
SUBSTANCE: invention refers to application of oligopeptide chosen from a group consisting of tripeptide of general formula X-Pro-Tyr (X-P-Y), in which X can be chosen from a group consisting of Ile (I), Val (V), Ala (A), Trp (W), Leu (L), Phe (F), Gly (G), Glu (E) and Asn (N), or peptides including the above tripeptide, in medicine for immunomodulation. Besides, application of the above oligopeptide for production of remedy to be used as an immunomodulator is disclosed. Immunomodulating pharmaceutical composition containing an effective amount of the above oligopeptide, as well as a vaccine containing it are disclosed. Besides, a method for reinforcement of mammal immune system, as well as a method for improvement of immunogenic activity of vaccine composition using the above immunomodulating composition are disclosed. A method providing immunoreactivity to peptide or improvement of peptide immunoreactivity with a peptide compound with the above oligopeptide is disclosed.
EFFECT: use of oligopeptides in medicine for immunomodulation.
19 cl, 2 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| COMPOSITIONS OF VACCINES AGAINST NEOPLASIA AND METHODS FOR OBTAINING THEREOF | 2016 |
|
RU2753246C2 |
| COMBINATION THERAPY OF ANTIBODY TO PROGASTRIN AND IMMUNOTHERAPY FOR CANCER TREATMENT | 2018 |
|
RU2784604C2 |
| COMPOSITIONS OF IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATES AND USE THEREOF | 2015 |
|
RU2720295C2 |
| ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION | 2018 |
|
RU2745451C1 |
| PEPTIDE OBTAINED FROM DEPDC1 AND VACCINE CONTAINING IT | 2016 |
|
RU2765574C2 |
| VACCINE COMPOSITION FOR TREATMENT OF CANCER | 2018 |
|
RU2782261C2 |
| CYTOMODULATING LIPOPHILIC PEPTIDES FOR MODULATION OF IMMUNE SYSTEM ACTIVITY AND SUPPRESSION OF INFLAMMATION | 1998 |
|
RU2214417C2 |
| ANTIBODY-DRUG CONJUGATES CONTAINING HERBOXYDIENE-BASED SPLICING MODULATOR, AND METHODS OF USE THEREOF | 2019 |
|
RU2820607C2 |
| COMPOSITIONS AND METHODS FOR DIAGNOSTICS AND TREATMENT OF TUMOUR | 2010 |
|
RU2563359C2 |
